Cisatracurium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children

Paediatric Anaesthesia

Volumn 21, Issue 3, 2011, Pages 341-346

  Withington, Davinia ^a   Ménard, Guillaume ^b   Varin, France ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

cisatracurium; hypothermic cardiopulmonary bypass; pediatric; pharmacodynamics; pharmacokinetics

Indexed keywords

CISATRACURIUM;

ADOLESCENT; ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDUCED HYPOTHERMIA; INFUSION RATE; MALE; MEDICAL RECORD REVIEW; NEUROMONITORING; NEUROMUSCULAR FUNCTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN TEMPERATURE; STEADY STATE;

ATRACURIUM; BODY TEMPERATURE; CALIBRATION; CARDIOPULMONARY BYPASS; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROMYOGRAPHY; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPOTHERMIA, INDUCED; INFANT; MALE; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SKIN TEMPERATURE;

EID: 79951656323     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2010.03514.x     Document Type: Article

References (22)

1. Wastila WB, Maehr RB, Turner GL, et al. Comparative pharmacology of cisatracurium (51W89) atracurium, and five isomers in cats. Anesthesiology 1996; 85: 169-177. (Pubitemid 26234709)
2. Heier T, Caldwell JE, Sessler D, et al. Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide-isoflurane anesthesia in humans. Anesthesiology 1991; 74: 815-819.
3. Cammu G, Coddens J, Hendrickx J, et al. Dose requirements of infusions of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass. Br J Anaesth 2000; 84: 587-590. (Pubitemid 30229599)
4. Rebeyka I,. Hypothermia. In:, Jonas RA, Elliott MJ, eds. Cardiopulmonary Bypass in Neonates, Infants and Young Children. Oxford: Butterworth Heinemann, 1994: 54-66.
5. Withington DE, Menard G, Harris J, et al. Vecuronium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children. Can J Anesth 2000; 47: 1188-1195. (Pubitemid 32098994)
6. Sumner E,. Anesthesia for subjects with cardiac disease. In:, Hatch DJ, Sumner E, eds. Pediatric Anesthesia, 2nd edn. London, UK: Arnold, 2000: 355.
7. Greeley WJ, Steven JM, Nicolson SC,. Anesthesia for pediatric cardiac surgery. In:, Miller RD, ed. Miller's Anesthesia, 6th edn. Philadelphia, PA: Elsevier Churchilll Livingstone, 2005: 2005-2049.
8. Saitoh Y, Fujii Y, Takahashi K, et al. Recovery of post-tetanic count and train-of-four responses at the great toe and thumb. Anaesthesia 1998; 53: 244-248. (Pubitemid 28097461)
9. Erkola O, Rautoma P, Meretoja O,. Interaction between mivacurium and succinylcholine. Anesth Analg 1995; 80: 534-537.
10. Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51: 789-808. (Pubitemid 47063004)
11. Meretoja OA,. Vecuronium infusion requirements in pediatric subjects during fentanyl- N2O-O2 anesthesia. Anesth Analg 1989; 68: 20-24. (Pubitemid 19042925)
12. Denny NM, Kneeshaw JD,. Vecuronium and atracurium infusions during hypothermic cardiopulmonary bypass. Anesthesia 1986; 41: 919-922. (Pubitemid 16014235)
13. Bryant BJ, James CD, Cook DR, et al. High performance liquid chromatographic assay for cisatracurium and its metabolites in human urine. J Liq Chromatogr Relat Technol 1997; 20: 2041-2051. (Pubitemid 27313806)
14. Peters JW, Anderson BJ, Simons SH, et al. Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates. Intensive Care Med 2005; 31: 257-263. (Pubitemid 40362275)
15. Buzello W, Pollmaecher T, Schluermann D, et al. The influence of hypothermic cardiopulmonary bypass on neuromuscular transmission in the absence of muscle relaxants. Anesthesiology 1986; 64: 279-281. (Pubitemid 16133163)
16. Buzello W, Schluermann D, Pollmaecher T, et al. Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium, and vecuronium. Anesthesiology 1987; 66: 842-846. (Pubitemid 17088993)
17. dHollander AA, Duvaldestin P, Henzel D, et al. Variations in pancuronium requirement, plasma concentration and urinary excretion induced by cardiopulmonary bypass with hypothermia. Anesthesiology 1983; 58: 505-509. (Pubitemid 13107089)
18. Flynn PJ, Hughes R, Walton B,. Use of atracurium in cardiac surgery involving cardiopulmonary bypass with induced hypothermia. Br J Anaesth 1984; 56: 967-971.
19. Smeulers NJ, Wierda JMKH, van den Broek L, et al. Hypothermic cardiopulmonary bypass influences the concentration-response relationship and the biodisposition of rocuronium. Eur J Anaesthesiol 1995; 12 (Suppl 11): 91-94.
20. Smeulers NJ, Wierda JNKH, van den Broek L, et al. Effects of hypothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium. J Cardiothorac Vasc Anesth 1995; 9: 700-705. (Pubitemid 26016538)
21. Roy JJ, Varin F,. Physicochemical properties of neuromuscular blocking agents and their impact on the pharmacokinetic-pharmacodynamic relationship. Br J Anaesth 2004; 93: 241-248. (Pubitemid 39117399)
22. Cameron M, Donati F, Varin F,. In vitro plasma protein binding of neuromuscular blocking agents in different subpopulations of subjects. Anesth Analg 1995; 81: 1019-1025.